|350 Capital||Canada, Ontario, Toronto|
|ARCH Healthcare Fund||-|
|Atlas Pacific Capital||California, San Jose, United States|
|Avendus Capital||New York, New York, United States|
|Blue Cloud Ventures||New York, New York, United States|
|Ensys Capital||Austin, Texas, United States|
|Gabriel Capital Management||New York, New York, United States|
|Heyu Ziben||China, Guangdong, Shenzhen|
|HLM Management Company||Boston, Massachusetts, United States|
|HomeAway||Austin, Texas, United States|
|HP Ventures Group||Chicago, Illinois, United States|
|i4g Investment||Austria, Vienna|
|ITX Corporation||New York, Pittsford, United States|
|Jadebird Capital||Beijing, Beijing, China|
|Premier Partners||Seoul, Seoul-t'ukpyolsi, South Korea|
|Southeast Minnesota Capital Fund||Minnesota, Rochester, United States|
|ZB.COM||Switzerland, Zürich, Zurich|
|Zhejiang Xunguang Touzi Guanli Youxian Gongsi||China, Zhejiang, Zhoushan|
|18 Apr 2022||Shanghai, China|
|$46M||11 Mar 2022||Shanghai, China|
|$1B||30 Nov 2021||Shanghai, Shanghai, China|
|$309M||25 Nov 2021||Haidian District, Beijing, China|
|09 Oct 2021||-|
|$46M||09 Aug 2021||Dongcheng District, Beijing, China|
|$154M||08 Apr 2021||San Jose, California, United States|
|$2B||30 Mar 2021||Shanghai, China|
|$16M||24 Feb 2021||Fengtai District, Beijing, China|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.